Literature DB >> 10028092

Herpes simplex virus encephalitis: chronic progressive cerebral magnetic resonance imaging abnormalities in patients despite good clinical recovery.

U K Meyding-Lamadé1, W R Lamadé, B T Wildemann, K Sartor, W Hacke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10028092     DOI： 10.1086/517183

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  11 in total

1.  Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.

Authors:  Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

2.  Chronic active herpes simplex type 2 encephalitis in an asymptomatic immunocompetent child.

Authors:  William D Brown; Elaine L Bearer; John E Donahue
Journal:  J Child Neurol       Date:  2010-02-22       Impact factor: 1.987

3.  The case for immunomodulatory approaches in treating HSV encephalitis.

Authors:  Chandran Ramakrishna; Harry Openshaw; Edouard M Cantin
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

Review 4.  [Acute viral and emerging viral CNS infections].

Authors:  S Menon; T Lenhard; U Meyding-Lamadé
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 5.  Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Clin Microbiol Rev       Date:  2020-02-12       Impact factor: 26.132

6.  Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis.

Authors:  Anibal G Armien; Shuxian Hu; Morgan R Little; Nicholas Robinson; James R Lokensgard; Walter C Low; Maxim C-J Cheeran
Journal:  Brain Pathol       Date:  2009-11-05       Impact factor: 6.508

Review 7.  Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis.

Authors:  Hui Liu; Ke Qiu; Qiang He; Qiang Lei; Wei Lu
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-19       Impact factor: 4.147

8.  Aquaporin 4 regulation during acute and long-term experimental Herpes simplex virus encephalitis.

Authors:  F J Martinez Torres; D Völcker; N Dörner; Th Lenhard; S Nielsen; J Haas; K Kiening; U Meyding-Lamadé
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

9.  Are steroids a beneficial adjunctive therapy in the immunosuppressed patient with herpes simplex virus encephalitis?

Authors:  Karlo J Lizarraga; Lucien C Alexandre; Ciro Ramos-Estebanez; Amedeo Merenda
Journal:  Case Rep Neurol       Date:  2013-03-21

10.  Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933].

Authors:  Francisco Martinez-Torres; Sanjay Menon; Maria Pritsch; Norbert Victor; Ekkehart Jenetzky; Katrin Jensen; Eva Schielke; Erich Schmutzhard; Jan de Gans; Chin-Hee Chung; Steffen Luntz; Werner Hacke; Uta Meyding-Lamadé
Journal:  BMC Neurol       Date:  2008-10-29       Impact factor: 2.474
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.